CN1286097A - Medical powder or capsule for treating gastropathies - Google Patents
Medical powder or capsule for treating gastropathies Download PDFInfo
- Publication number
- CN1286097A CN1286097A CN00119684A CN00119684A CN1286097A CN 1286097 A CN1286097 A CN 1286097A CN 00119684 A CN00119684 A CN 00119684A CN 00119684 A CN00119684 A CN 00119684A CN 1286097 A CN1286097 A CN 1286097A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- capsule
- powder
- active carbon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese-medicine in the form of powder or capsules for treating the gastropathies, such as gastric ulcer, hemorrhage in upper digestive tract, duodenal sphere ulcer, different gastritises, etc is prepared from 8 Chinese-medicinal materials including cyperus tuber, cyanide, Sichuan chinaberry, white peony root, etc. Its advantages are high cure rate up to 81.3% and high total effective rate up to 9.5% or more.
Description
The present invention relates to technical field of medicaments, specifically a kind of powder or capsule for the treatment of various stomach.
Though the Chinese medicine of treatment gastropathy is more in the prior art, but mostly be single treatment targetedly, and the effect of treatment is undesirable, the WEIFUCHUN medicine of the treated atrophic gastritis of producing as Hangzhou, owing in medicine is joined, contain wild Pedicellus et Pericarpium Trapae Radix Notoginseng, and this wild raw material lacks very much now, therefore has the not good enough phenomenon of curative effect.
The object of the present invention is to provide a kind of powder or capsule for the treatment of various stomach, and the effect of treatment is better.
Technical scheme of the present invention is achieved in that a kind of powder or capsule for the treatment of various stomach, it is characterized in that: described powder or capsule are made up of Rhizoma Cyperi, Radix Et Rhizoma Nardostachyos, Rhizoma Kaempferiae, Fructus Toosendan, the Radix Paeoniae Alba, Endoconcha Sepiae, active carbon, the Radix Linderae, its weight percentages of components is Rhizoma Cyperi 2-5%, Radix Et Rhizoma Nardostachyos 2-8%, Rhizoma Kaempferiae 3-4%, Fructus Toosendan 5-10%, Radix Paeoniae Alba 5-10%, Endoconcha Sepiae 10-20%, active carbon 10-20%, Radix Linderae 10-40%.
A kind of powder or capsule for the treatment of various stomach, it is characterized in that: described powder or capsule are made up of Rhizoma Cyperi, Radix Et Rhizoma Nardostachyos, Rhizoma Kaempferiae, Cordyceps, Fructus Toosendan, the Radix Paeoniae Alba, Endoconcha Sepiae, active carbon, the Radix Linderae, its weight percentages of components is Rhizoma Cyperi 2-5%, Radix Et Rhizoma Nardostachyos 2-8%, Rhizoma Kaempferiae 3-4%, Cordyceps 2-4%, Fructus Toosendan 5-10%, Radix Paeoniae Alba 5-10%, Endoconcha Sepiae 10-20%, active carbon 10-20%, Radix Linderae 10-40%.
The present invention comes out according to secret prescription handed down in the family from generation to generation and several generations' the summary of experience of practising medicine, the various stomach that it is difficult to cure for medical circle has fairly obvious curative effect, as gastric ulcer or with upper gastrointestinal hemorrhage, duodenal bulbar ulcer, bile reflux gastritis, chronic atrophic gastritis, light, in, the cure rate of gastropathy such as severe erosion, helicobacter pylori (positive), intestinal epithelial metaplasia, atypical hyperplasia is up to 81.3%, total effective rate reaches 95% to be specially:
1, duodenal bulbar ulcer, gastric ulcer or with the gastropathy of upper gastrointestinal hemorrhage symptom, treatment number 10850 people, through taking medicine 10633 people of sx or healing, effective percentage 98%, 10307 people of Zhi Yuing wherein, cure rate 95%;
2, chronic superficial antral gastritis, treatment number 5670 people, through taking medicine 5386 people of sx or healing, effective percentage 95%, 4876 people of Zhi Yuing wherein, cure rate is 86%;
3, chronic superficial atrophic gastritis companion erosive gastropathy, treatment number 387 people, through taking medicine 348 people of sx or healing, effective percentage 90%, 309 people of Zhi Yuing wherein, cure rate 80%.
Above treatment number is to come out according to the case notes in more than 30 years.
Below the invention will be further described and provide embodiment.
The present invention is made up of Rhizoma Cyperi, Radix Et Rhizoma Nardostachyos, Rhizoma Kaempferiae, Fructus Toosendan, the Radix Paeoniae Alba, Endoconcha Sepiae, active carbon, eight kinds of Chinese medicines of the Radix Linderae, according to pharmacology analysis, the Rhizoma Cyperi traditional Chinese medical science wherein think have depressed liver-energy dispersing and QI regulating, the effect of menstruction regulating and pain relieving, and can separate the card of six kinds of stagnation-syndromes, doctor trained in Western medicine is studied it and is had anti-inflammatory effect, resisting pathogenic microbes and choleretic effect; The Radix Et Rhizoma Nardostachyos traditional Chinese medical science think have regulating QI to relieve pain, activating spleen and strengthening stomach, doctor trained in Western medicine research has the spasm of separating effect, the spasm that can antioxidation barium causes, the effect that also have anti-arrhythmia, resists myocardial ischemia, nardosin has hypotensive effect after giving Hypertensive Rats oral; The traditional Chinese medical science is thought spleen pertaining to the earth, like warm-dryness syndrome, dislike cold wetting, and Rhizoma Kaempferiae has warming middle-JIAO dehumidifying, promote qi circulation digestion promoting, analgesic effect, the dampness that adopts Rhizoma Kaempferiae to remove taste is the choosing of ideal, doctor trained in Western medicine research thinks to have antitumaous effect in the Rhizoma Kaempferiae medicine, can obviously suppress human cervical carcinoma's HeLa cell that goes down to posterity, its IC50 that suppresses the HeLa cell is 35ug/ml; The Fructus Toosendan traditional Chinese medical science think have soothing the liverly expel the heat-evil, promoting the circulation of QI to relieve pain, parasiticidal effect, the transfer function of doctor trained in Western medicine research between can the block nerves neuromuscular junction; The Radix Paeoniae Alba traditional Chinese medical science thinks to have nourishing blood and the pain relieving of getting a breathing space, the effect of holding back the liver suppressing the hyperactive liver, doctor trained in Western medicine research has tangible analgesia to conciliate the spasm effect, Radix Paeoniae is sweet more weak antiinflammatory action, acid and dextran toes swelling has inhibitory action in various degree to the yeast chondrus ocellatus Holmes, contain paeonol in the Radix Paeoniae, the benzoyl Radix Paeoniae is sweet and the oxidation Radix Paeoniae is sweet that antiinflammation also arranged, and Radix Paeoniae can strengthen the immunologic function of human body, promote the phagocytic function of the intravital macrophage of people, Radix Paeoniae also has protecting liver and detoxication and antineoplastic action on pharmacology; The Endoconcha Sepiae traditional Chinese medical science think have astringing to arrest bleeding, treating spontaneous emission and leukorrhagia, relieving gastric hyperacidity to alleviate stomachache, removing dampness hold back effects such as scar, doctor trained in Western medicine research has radioprotective, the effect of bone defect repair, and antitumor, antiulcer action; The active carbon traditional Chinese medical science thinks to have but effect such as wind of hemostasis, pain relieving; The Radix Linderae traditional Chinese medical science think have promoting the circulation of QI to relieve pain, warming kidney for dispelling cold, doctor trained in Western medicine research have anti-simple spore rash, virus, the effect of antihistamine hemostatic, in order to increase therapeutic effect, also can increase Cordyceps outside these eight kinds of medicines in addition, the traditional Chinese medical science thinks that Cordyceps has the function that strengthens body immunity.
Eight flavors or nine flavor Chinese medicines are mixed by above-mentioned proportioning, be ground into powder again, powder size is generally the 80-200 order, also can make capsule, and the present invention also has the convenience of taking medicine, and is evident in efficacy, and gastropathy is difficult for recurrence, does not produce advantages such as drug dependence and toxic and side effects.
Provide embodiment and three cases below
Embodiment 1
With percentage by weight be, after Rhizoma Cyperi 2%, Radix Et Rhizoma Nardostachyos 6%, Rhizoma Kaempferiae 4%, Fructus Toosendan 5%, the Radix Paeoniae Alba 10%, Endoconcha Sepiae 15%, active carbon 18%, the Radix Linderae 40% carry out proportioning, be ground into powder, granularity is 100 orders.
Embodiment 2
With percentage by weight be, after Rhizoma Cyperi 4%, Radix Et Rhizoma Nardostachyos 5%, Rhizoma Kaempferiae 4%, Fructus Toosendan 9%, the Radix Paeoniae Alba 8%, Endoconcha Sepiae 19%, active carbon 16%, the Radix Linderae 35% carry out proportioning, be ground into powder, granularity is 150 orders, makes capsule again.
Embodiment 3
With percentage by weight be, after Rhizoma Cyperi 5%, Radix Et Rhizoma Nardostachyos 8%, Rhizoma Kaempferiae 3%, Fructus Toosendan 6%, the Radix Paeoniae Alba 9%, Endoconcha Sepiae 15%, active carbon 20%, the Radix Linderae 34% carry out proportioning, be ground into powder, granularity is 90 orders.
Embodiment 4
With weight percentages of components be, Rhizoma Cyperi 3%, Radix Et Rhizoma Nardostachyos 4%, Rhizoma Kaempferiae 3%, Cordyceps 3%, Fructus Toosendan 8%, the Radix Paeoniae Alba 8%, Endoconcha Sepiae 20%, active carbon 20%, the Radix Linderae 31% are ground into powder, and granularity is 200 orders, mixes again, makes capsule.
Embodiment 5
With weight percentages of components be, Rhizoma Cyperi 5%, Radix Et Rhizoma Nardostachyos 8%, Rhizoma Kaempferiae 4%, Cordyceps 4%, Fructus Toosendan 10%, the Radix Paeoniae Alba 10%, Endoconcha Sepiae 20%, active carbon 18%, the Radix Linderae 21% are ground into powder, and granularity is 100 orders, mixes again, makes capsule.
Embodiment 6
With weight percentages of components be, Rhizoma Cyperi 5%, Radix Et Rhizoma Nardostachyos 7%, Rhizoma Kaempferiae 3%, Cordyceps 2%, Fructus Toosendan 7%, the Radix Paeoniae Alba 8%, Endoconcha Sepiae 20%, active carbon 20%, the Radix Linderae 28% are ground into powder, and granularity is 180 orders, mixes again, makes capsule.
Case 1
The village, man 48 years old works in administration department of Shanghai Cigarette Factory, the outpatient service of coming on October 29 in 95 year, gastropathy history 27 years, gastral cavilty portion pain, neural emission back, pain has regularly, distension, poor appetite, it is uncomfortable to lay one's hand on pressure, with headache, dizzy, borborygmus are done when half congealed during stool, light red tongue, tongue fur is white, stringy and tense pulse, and Xinhua's hospital gastroscope is checked, stomach angle ulcer (active stage 0.8 * 0.8cm), companion's atrophic antral gastritis, erosive, pathological replacement, stomach angle mucosa chronic inflammatory disease, companion's moderate epithelial metaplasia, the helicobacter pylori positive, capsule was taken 42 days among the adapted embodiment 5, further consultation again, preceding disease subtracts greatly, have a very good appetite, readme does not have uncomfortable symptom, light red tongue, white and thin fur, stringy pulse, continued to take Chinese medicine 42 days, the check gastroscope, superficial gastritis continues to take medicine again and heals.
Case 2
Gong, woman 35 years old works in last steel three factories, gastropathy history 2 years, gastralgia, belch, noisy, gastrorrhagia 2 times, poor appetite, emaciated physique, normal through being with, tongue is dark, white and thin fur, stringy pulse, gastroscope duodenal bulbar ulcer companion atrophy part gastritis is taken the Chinese medicine powder 42 days of embodiment 2, two examine before disease subtracts greatly, the time discomfort is arranged, continue to take recovery from illness in 42 days.
Case 3
Zhou Lijun, man 29 years old, Minhang District discipline Wang Zhenren, gastropathy history 7 years, gastral cavilty portion pain, regularly paroxysmal pain is alleviated after the feed, distension, belch, noisy hunger sensation, poor appetite, bowel dysfunction, lay one's hand on press comfortable, neural emission back, half congealed during stool, light red tongue, greasy in vain, the stringy pulse of tongue, the gastroscopy duodenal bulbar ulcer, companion's antral gastritis is joined the capsule of embodiment 6 and was taken 42 days, the locals saw a doctor afterwards, talked about week and fully recovered, was that he introduces and sees a doctor.
Claims (2)
1, a kind of powder or capsule for the treatment of various stomach, it is characterized in that: described powder or capsule are made up of Rhizoma Cyperi, Radix Et Rhizoma Nardostachyos, Rhizoma Kaempferiae, Fructus Toosendan, the Radix Paeoniae Alba, Endoconcha Sepiae, active carbon, the Radix Linderae, its weight percentages of components is Rhizoma Cyperi 2-5%, Radix Et Rhizoma Nardostachyos 2-8%, Rhizoma Kaempferiae 3-4%, Fructus Toosendan 5-10%, Radix Paeoniae Alba 5-10%, Endoconcha Sepiae 10-20%, active carbon 10-20%, Radix Linderae 10-40%.
2, a kind of powder or capsule for the treatment of various stomach, it is characterized in that: described powder or capsule are made up of Rhizoma Cyperi, Radix Et Rhizoma Nardostachyos, Rhizoma Kaempferiae, Cordyceps, Fructus Toosendan, the Radix Paeoniae Alba, Endoconcha Sepiae, active carbon, the Radix Linderae, its weight percentages of components is Rhizoma Cyperi 2-5%, Radix Et Rhizoma Nardostachyos 2-8%, Rhizoma Kaempferiae 3-4%, Cordyceps 2-4%, Fructus Toosendan 5-10%, Radix Paeoniae Alba 5-10%, Endoconcha Sepiae 10-20%, active carbon 10-20%, Radix Linderae 10-40%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN00119684A CN1089591C (en) | 2000-08-22 | 2000-08-22 | Medical powder or capsule for treating gastropathies |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN00119684A CN1089591C (en) | 2000-08-22 | 2000-08-22 | Medical powder or capsule for treating gastropathies |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1286097A true CN1286097A (en) | 2001-03-07 |
CN1089591C CN1089591C (en) | 2002-08-28 |
Family
ID=4587921
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN00119684A Expired - Fee Related CN1089591C (en) | 2000-08-22 | 2000-08-22 | Medical powder or capsule for treating gastropathies |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1089591C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103845673A (en) * | 2014-03-20 | 2014-06-11 | 张小丽 | Medicine for treating upper gastrointestinal hemorrhage and preparation method thereof |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1315512C (en) * | 2004-12-10 | 2007-05-16 | 赵宏 | Medicine for treating gastritis and its preparation method |
CN101108229B (en) * | 2006-07-21 | 2010-05-12 | 山东轩竹医药科技有限公司 | Medicament for treating tummy bug |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1100651A (en) * | 1994-03-15 | 1995-03-29 | 广东医学院医药科技开发中心 | Chinese herbal prepn. for curing chronic gastroenteritis and peptic gastric ulcer |
-
2000
- 2000-08-22 CN CN00119684A patent/CN1089591C/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103845673A (en) * | 2014-03-20 | 2014-06-11 | 张小丽 | Medicine for treating upper gastrointestinal hemorrhage and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1089591C (en) | 2002-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101066434B (en) | Omeprazole-containing medicine | |
CN101066435A (en) | Iprazole containing medicine | |
CN101269200A (en) | Chinese-western medicine composition containing carafate for treating gastric ulcer | |
CN1089591C (en) | Medical powder or capsule for treating gastropathies | |
CN100534516C (en) | Medicine containing rabeprazole for treating gastric ulcer | |
CN103041365A (en) | Medicament for treating gastric ulcer | |
CN100515485C (en) | Medicine composition for treating gastric ulcer | |
CN100396311C (en) | Medicine for treating recurrent peptic ulcer | |
CN1255165C (en) | Traditional Chinese medicinal preparation for treating iternal-external ulcer and its preparation method | |
CN1903326A (en) | Medicine composition for treating digestive exulceratio | |
CN101401899A (en) | Medicament for treating gastric, duodenal ulcer | |
CN108743694A (en) | A kind of Chinese medicine composition and preparation method thereof for treating stomach trouble | |
CN101199765B (en) | Medicament for treating stomach disease | |
CN1264563C (en) | Gastropathy treating medicine and its preparation | |
CN1277571C (en) | Chinese medicine preparation for stomach diseases | |
CN1105875A (en) | Medicine for treating cirrhosis ascites disease | |
CN101926958B (en) | Chinese and Western medicine composition containing carbenoxolone sodium | |
CN101066418B (en) | Medicine containing colloidal bismuth for treating gastric uncer | |
CN1118294C (en) | Process for preparing 'Weilinsan' | |
CN1108165C (en) | Traditional Chinese medicinal preparation for treating cancer | |
CN105031587A (en) | Chinese herba preparation for curing gastrointestinal diseases | |
CN105168594A (en) | Traditional Chinese medicine for treating gastric ulcer | |
CN1113659C (en) | Chinese patent medicine for treating gastritis | |
CN101810828B (en) | Combination medicament containing teprenone | |
CN101732664B (en) | Enprostil-containing Chinese and Western medicinal composition for treating gastric ulcer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20020828 Termination date: 20160822 |